Contact
Get in touch
Press, general, research, and collaboration enquiries. We prefer email so messages can be routed to the right team.
Press and general enquiries. Please do not send personal health information, clinical records, or patient-identifiable data by email. This is not a diagnosis service, crisis line, or trial enrolment portal.
Researchers & collaborators
Scientific or partnership enquiries can use the same address; please state your institution and the nature of the enquiry in the subject line.
Journalists
For press, email with “Press” in the subject. We aim to respond carefully rather than instantly.
Privacy note
Email is processed for enquiry handling only. Do not include sensitive personal or health data. Prefer organisational contact details where possible.
Investor materials
There is no open subscription here. Any future private process would be eligibility-gated. The investor portal shell is labelled In development.